Sustained efficacy with long鈥憈erm use, maintaining ~65% total lesion reduction in a single arm study through 12 months, which supports once鈥慸aily, ongoing acne control.6

Proven efficacy across diverse patient populations, with consistent results and favorable tolerability across skin tones.













“This milestone reflects a meaningful advancement for patients, as it expands access to a clinically proven, dual-active acne solution without the need for a prescription. In my practice, the combination of easy access and a simple, once-daily application can help patients use treatment more consistently in their treatment journey for the best possible outcomes.”











HEATHER WOOLERY-LLOYD, MD





BOAR
=*=*=*=*=*=
当前为第6/10页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页